Pantacido 20 mg
Pantacido 20 mg is a medicine authorised by Swissmedic under authorisation number 69376. The authorisation holder is NOBEL Pharma Schweiz AG. The medicinal product code is Synthetic medicines and the dispensing category is D: Supplied in pharmacies and drugstores after specialist advice, without a prescription. First authorisation was granted on 05 May 2023 and the authorisation is valid without a time limit. ATC code A02BC02 places the medicine in the group Drugs for acid related disorders.
| Authorisation number | 69376 |
|---|---|
| Name | Pantacido 20 mg |
| Full name | Pantacido 20 mg, magensaftresistente Tabletten |
| Authorisation holder | NOBEL Pharma Schweiz AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | D · No prescription, with advice |
| ATC code | A02BC02 |
| First authorisation | 05 May 2023 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Pantacido 20 mg, magensaftresistente Tabletten | D | 05 May 2023 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 10 | 7 | Tablette(n) | A02BC02 | 04.99.0. | D |
| 11 | 14 | Tablette(n) | A02BC02 | 04.99.0. | D |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Pantacido 20 mg authorised in Switzerland?
Yes. Pantacido 20 mg is authorised by Swissmedic under authorisation number 69376, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Pantacido 20 mg have?
Pantacido 20 mg is in dispensing category D. Supplied in pharmacies and drugstores after specialist advice, without a prescription.
Who is the authorisation holder of Pantacido 20 mg?
The authorisation holder is NOBEL Pharma Schweiz AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.